Zhiwei Wang received his M.D. degree from the Anhui Bengbu Medical College, China and his Ph.D. degree from the Wayne State University, Detroit, Mich, USA. He has completed postdoctoral fellowships at the Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA. He is currently a Faculty in the Beth Israel Deaconess Medical Center, Harvard medical School, USA. He has published more than 110 papers in peer-reviewed journals with Hirsch factor 25, total impact factor 500, and more than 1900 citations. He has served as an ad hoc reviewer of grant and as an ad hoc reviewer of papers for more than 30 Journals. Dr. Wang's research interests are focused on the roles of cell signaling pathways such as Notch, FoxM1, and E3 ubiquitin ligases in development and progression of human cancer. Moreover, He is also interested in roles of microRNA and stem cells in drug resistance.
Biography Updated on 9 November 2011